An observational study in the Detection of Prostate Cancer in Men, sponsored by Al-Hawash Private University. Enrolling by invitation at 1 site in Syria. Open to male participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-07-20.
Sponsored by Al-Hawash Private University · Observational
Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.
This study aims to assess the awareness, attitudes, and practices regarding prostate cancer screening among men in the middle region of Syria, with the goal of identifying barriers to early detection and informing public health interventions.
7,046 studies on the registry are indexed under Prostatic Neoplasms; 1,580 are open to participants now.
This study's planned enrollment of 1,000 is above the median of 200 across 1,310 observational studies indexed under Prostatic Neoplasms.
Browse Prostatic Neoplasms studies →Al-Hawash Private University is the lead sponsor of 6 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Detection of Prostate cancer in syrian men aged 40-65
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Prostate-Specific Antigen test, a blood test used to measure the level of PSA in a man's blood. PSA is a protein produced by the prostate gland, and elevated levels can indicate various conditions, including prostate cancer, benign prostatic hyperplasia (BPH), or prostatitis.
A digital rectal exam (DRE) is a procedure where a doctor inserts a lubricated, gloved finger into the rectum to check for abnormalities.
Number of ptients with early signs of prostate cancer
Time frame: From Participant enrolment to the end of the study at 2 weeks
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Al-Hawash Private University